UPPA Test easily Established Mercury Poisoning
WASHINGTON, DC – Recent peer-reviewed
scientific/medical studies by Nataf et al.
(2006) and by Geier and Geier (2006) leave little doubt that
many children with autism spectrum disorders (ASDs) are indeed
mercury poisoned. These studies utilized urinary porphyrin
profile analysis (UPPA) to assess body-burden and physiological
effects of mercury in autistics. Today, any parent, physician,
or healthcare provider can easily confirm whether a non-chelated
autistic is mercury poisoned by having UPPA testing run at
Laboratory Corporation of America (LabCorp) (CLIA-certified,
Test#120980) or Laboratoire Philippe Auguste (ISO-certified,
Urine Porphyrin Profile).
UPPA is a highly accurate, inexpensive, non-invasive, and
routinely available method for estimating body-burden and
toxicity of mercury. Numerous peer-reviewed scientific/medical
papers published over the past 40 years, many of them supported
by the US NIH, have proven the validity of using UPPA to
identify mercury poisoning.
UPPA profiling, unlike attempts to directly measure mercury
in the blood, urine or feces, or in tissues (e.g., hair and
nail), is a proven method for assessing mercury toxicity.
Using
UPPA, Nataf et al. (2006) studied the urinary porphyrin patterns
in French children using the results reported by Laboratoire
Philippe Auguste. Similarly, Geier and Geier (2006) studied
the urinary porphyrin patterns in US children using the results
reported by LabCorp.
Both published studies:
• Clearly demonstrated that non-chelated autistics had
porphyrin patterns indicative of clinical mercury toxicity,
while normal children and their normal sibling controls did
not.
• Found that the more severely affected the ASD children
were the higher their evidence of mercury toxicity.
• Established that treating autistics with chelating
agents resulted in lower mercury specific urinary porphyrins,
which corresponded to apparent reductions in the mercury
body-burden of these children.
Many other physicians who take care of ASD patients have
ordered UPPA testing and confirmed the observations made
by Nataf et al. (2006) and Geier and Geier (2006).
Thus, urinary porphyrin profile testing is being successfully
used to:
• Demonstrate the role of mercury in populations of
autistics,
• Identify those children and adults who are mercury
poisoned, and
• Track mercury excretion from affected children undergoing
treatment.
For the past several years there has been a raging controversy
as to whether or not mercury in medicines, especially in
vaccines, has caused the dramatic rise in the rate of children
diagnosed with an ASD. Many experts have insisted ASDs are
caused by some yet-to-be-identified genetic cause. A paper
recently published in Nature Genetics described the results
of multi-million-dollar genetics study (which studied a thousand
plus families with at least two autistics using in-depth
genetic screening). Tellingly, the authors reported, “None
of our linkage results can be interpreted as ‘statistically
significant’…” (The Autism Genome Project
Consortium, 2007). This makes it unlikely that purely genetic
aberrations are the root cause of most ASD cases.
With the current porphyrin study results, public health
officials should now publicly admit what they have been saying
in their private transcripts and memos all along:
Mercury from Thimerosal-containing vaccines and other medicines
has been a major cause of ASD cases, which, according to
recent CDC (2007) estimates, may occur one in every 150 children.
CoMeD’s web site, http://www.Mercury-freeDrugs.org contains:
• Further information on how to order these tests,
• Full copies of the Nataf et al. (2006) and Geier and
Geier (2006) papers, and
• Some of the many published papers validating the UPPA
test.
back to top
back to vaccination index
page |
